stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

CAD 16.55

0.00 (0.00)%

CAD 4.44B

9.61M

N/A

CAD 18.50 (+11.78%)

Icon

APHA:CA

Aphria Inc (CAD)
COMMON STOCK | TSX
CAD 16.55
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

Buy

Average User
Rating

CAD 4.44B

CAD 18.50 (+11.78%)

CAD 16.55

Aphria Inc Stock Forecast

N/A

Based on the Aphria Inc stock forecast from 0 analysts, the average analyst target price for Aphria Inc is not available over the next 12 months. Aphria Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Aphria Inc is Neutral, which is based on 1 positive signals and 1 negative signals. At the last closing, Aphria Inc’s stock price was CAD 16.55. Aphria Inc’s stock price has changed by +0.00% over the past week, +0.00% over the past month and +0.00% over the last year.

No recent analyst target price found for Aphria Inc
No recent average analyst rating found for Aphria Inc

Company Overview

Aphria Inc. cultivates, processes, produces, markets, distributes, and sells medical cannabis in Canada and internationally. The company offers pharmaceutical-grade medical cannabis, adult-use cannabis, and cannabis-derived extracts and derivative cannabis products under the Sole...Read More

http://aphriainc.com

98 Talbot Street West, Leamington, ON, Canada, N8H 1M8

1,200

May

CAD

Canada

Adjusted Closing Price

Loading...

Technical Indicators

Unadjusted Closing Price

Loading...

Assets

Top Holdings

Top Sectors

Top Regions

Share Volume

Loading...

Relative Performance

Symbol Capital Gain Dividend Return Total Return
Loading...

Stocks Similar To Aphria Inc (Sector: Drug Manufacturers-Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
BHC:CA
Bausch Health Companies Inc +0.03 (+0.27%) CAD4.08B 11.95 10.20

ETFs Containing APHA:CA

Symbol Name APHA:CA's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About APHA:CA Stock

Stock Target Advisor's fundamental analysis for Aphria Inc's stock is Neutral.

Unfortunately we do not have enough data on APHA:CA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on APHA:CA's stock to indicate what its average analyst target is.

APHA:CA stock's Price/Earning ratio is 57.08. Based on this APHA:CA may be a overvalued for its sector.

The last closing price of APHA:CA's stock was CAD 16.55.

The most recent market capitalization for APHA:CA is CAD 4.44B.

Unfortunately we do not have enough analyst data on APHA:CA's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...